Filings (90d)
0
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Anders Ullman. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Zaccardelli - $11.26M in VRNA purchases and sales on record
- Mark W. Hahn - $11.26M in VRNA purchases and sales on record
- Kathleen A. Rickard - $1.94M in VRNA purchases and sales on record
- David R. Ebsworth - $303K in VRNA purchases and sales on record
- Christina Ackermann - $222K in VRNA purchases and sales on record
- Michael Austwick - $148K in VRNA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anders Ullman?
Anders Ullman is a corporate insider, tracked as Director of Verona Pharma plc (VRNA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Anders Ullman last file a Form 4?
The most recent primary Form 4 on record is dated 7 October 2025, one of 2 filings going back to 2025.
